2017
DOI: 10.1007/s11030-016-9717-4
|View full text |Cite
|
Sign up to set email alerts
|

Identification of potential glutaminyl cyclase inhibitors from lead-like libraries by in silico and in vitro fragment-based screening

Abstract: A glutaminyl cyclase (QC) fragment library was in silico selected by disconnection of the structure of known QC inhibitors and by lead-like 2D virtual screening of the same set. The resulting fragment library (204 compounds) was acquired from commercial suppliers and pre-screened by differential scanning fluorimetry followed by functional in vitro assays. In this way, 10 fragment hits were identified ([Formula: see text]5 % hit rate, best inhibitory activity: 16 [Formula: see text]). The in vitro hits were the… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
11
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 17 publications
(11 citation statements)
references
References 34 publications
0
11
0
Order By: Relevance
“…While 2D similarity search is useful for hit validation, pharmacophore matching is valuable for extending the activity space with novel chemotypes. Strategy I: Selection of the fragment library via direct 2D similarity search [72]. Collection of potential active fragments toward a biological target starts from the structure of known biologically active compounds (active chemical space), carrying out a 2D similarity search using multi-million compounds libraries (T ≥ 0.65) and then filtering the resulting analogues for physicochemical parameters reflecting the fragment criteria.…”
Section: Discussionmentioning
confidence: 99%
“…While 2D similarity search is useful for hit validation, pharmacophore matching is valuable for extending the activity space with novel chemotypes. Strategy I: Selection of the fragment library via direct 2D similarity search [72]. Collection of potential active fragments toward a biological target starts from the structure of known biologically active compounds (active chemical space), carrying out a 2D similarity search using multi-million compounds libraries (T ≥ 0.65) and then filtering the resulting analogues for physicochemical parameters reflecting the fragment criteria.…”
Section: Discussionmentioning
confidence: 99%
“…In 2016, Mária Szaszkó, István Hajdú et al obtained 204 QC inhibitory fragments by Fragment‐based drug discovery (FBDD) method based on a known QC inhibitor PBD150 . 15 fragments were chosen by the thermal shift assay with the shifted melting temperature >1 ○ C and 10 out of 15 fragments exhibited the QC inhibitory activities with IC 50 ranging from 12–122 uM.…”
Section: Qc Iinhibitorsmentioning
confidence: 99%
“…Therefore, molecular docking approaches are initially performed to preliminary estimate the ligand‐binding pose and affinity 41,42 . Moreover, molecular docking approaches have also been used for screening a large database of compounds, 43,44 which may consist of several millions of compounds such as ZINC, 45 ChEMBL, 46 PubChem, 47 and so forth. Therefore, although their accuracy is not very high, molecular docking approaches play an important role in CADD 48 …”
Section: Introductionmentioning
confidence: 99%